Kiniksa (NASDAQ: KNSA) CSO Tessari resigns, signs $450/hour consulting deal
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Kiniksa Pharmaceuticals International, plc reported that Chief Strategy Officer Eben Tessari has decided to resign to pursue another executive role in the life sciences industry. He will leave his officer role on May 15, 2026, but will continue supporting the company as a consultant.
Under a new Consulting Agreement effective May 15, 2026, Tessari will advise on strategic and operational matters and serve as a special advisor to the Science and Research Committee through May 15, 2027, with an option to renew. He will be paid $450 per hour, up to 20 hours per month, plus approved expenses. The company states his resignation is not due to any disagreement regarding its operations, policies, or practices.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Officer departure date: May 15, 2026
Consulting term start: May 15, 2026
Consulting term end: May 15, 2027
+2 more
5 metrics
Officer departure date
May 15, 2026
Date Eben Tessari leaves Chief Strategy Officer role
Consulting term start
May 15, 2026
Effective date of Consulting Agreement
Consulting term end
May 15, 2027
Scheduled end of initial consulting term
Hourly consulting rate
$450 per hour
Compensation for consulting services
Monthly hour cap
20 hours per month
Maximum billable consulting hours
Key Terms
Consulting Agreement, Emerging growth company, Item 5.02, Science and Research Committee
4 terms
Consulting Agreement financial
"Pursuant to a Consulting Agreement (the “Consulting Agreement”) between Mr. Tessari and the Company"
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Item 5.02 regulatory
"Item 5.02. Departure of Directors or Certain Officers; Election of Directors"
Science and Research Committee other
"serve as a special advisor to the Company’s Science and Research Committee"
FAQ
Why did Kiniksa (KNSA) Chief Strategy Officer Eben Tessari resign?
Eben Tessari resigned as Chief Strategy Officer to pursue another executive position in the life sciences industry. Kiniksa states his decision was not due to any disagreement regarding the company’s operations, policies, or practices, indicating an amicable and planned leadership transition rather than a conflict-driven departure.
When is Eben Tessari leaving his officer role at Kiniksa (KNSA)?
Eben Tessari will leave his position as Chief Strategy Officer on May 15, 2026. After stepping down from the executive role, he will continue working with Kiniksa as a consultant and special advisor to the Science and Research Committee under a defined one-year Consulting Agreement.
What are the main terms of Eben Tessari’s consulting agreement with Kiniksa (KNSA)?
The Consulting Agreement starts May 15, 2026 and ends May 15, 2027. Tessari will provide strategic and operational services and advise the Science and Research Committee, earning $450 per hour for up to 20 hours per month, plus reimbursement of reasonable pre-approved travel and out-of-pocket expenses.
Can Kiniksa (KNSA) or Eben Tessari terminate the consulting arrangement early?
Yes. The Consulting Agreement may be terminated by either Kiniksa or Eben Tessari upon prior written notice to the other party. This provides flexibility for both sides if circumstances change during the one-year term or any mutually agreed renewal period after May 15, 2027.
Is Eben Tessari’s consulting agreement with Kiniksa (KNSA) renewable?
The Consulting Agreement runs from May 15, 2026 to May 15, 2027 and may be renewed for an additional one-year period. Any renewal must be mutually agreed upon by both Kiniksa and Tessari, and would continue on the same terms and conditions specified in the current agreement.
What compensation will Kiniksa (KNSA) pay Eben Tessari as a consultant?
Kiniksa will pay Eben Tessari $450 per hour for consulting services, capped at 20 hours per month. He will also receive reimbursement for reasonable, pre-approved travel and out-of-pocket expenses incurred while performing strategic, operational, and advisory services for the company and its Science and Research Committee.